WallStreetZenWallStreetZen

NASDAQ: QTTB
Q32 Bio Inc Stock

$28.89+5.08 (+21.34%)
Updated Apr 12, 2024
QTTB Price
$28.89
Fair Value Price
N/A
Market Cap
$93.30M
52 Week Low
$8.24
52 Week High
$30.92
P/E
-0.82x
P/B
1.28x
P/S
30.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.16M
Earnings
-$112.96M
Gross Margin
100%
Operating Margin
-9,771.71%
Profit Margin
-9,771.7%
Debt to Equity
0.16
Operating Cash Flow
-$96M
Beta
1.18
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

QTTB Overview

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body’s first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32’s complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how QTTB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QTTB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
QTTB is good value based on its book value relative to its share price (1.28x), compared to the US Biotechnology industry average (5.93x)
P/B vs Industry Valuation
QTTB is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more QTTB due diligence checks available for Premium users.

Be the first to know about important QTTB news, forecast changes, insider trades & much more!

QTTB News

Valuation

QTTB fair value

Fair Value of QTTB stock based on Discounted Cash Flow (DCF)
Price
$28.89
Fair Value
-$0.35
Undervalued by
8,458.78%
QTTB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

QTTB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.82x
Industry
14.72x
Market
42.64x

QTTB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.28x
Industry
5.93x
QTTB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QTTB's financial health

Profit margin

Revenue
$0.0
Net Income
-$16.1M
Profit Margin
0%
QTTB's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
QTTB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$84.6M
Liabilities
$11.6M
Debt to equity
0.16
QTTB's short-term assets ($83.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QTTB's short-term assets ($83.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QTTB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QTTB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$21.6M
Investing
$31.7M
Financing
$14.0k
QTTB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

QTTB vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
QTTB$93.30M+21.34%-0.82x1.28x
CLSD$93.40M-3.85%-2.36x-5.87x
ATHA$93.52M-7.92%-0.79x0.72x
DMAC$92.24M-4.33%-4.05x1.81x
PMVP$92.08M+13.29%-1.24x0.41x

Q32 Bio Stock FAQ

What is Q32 Bio's quote symbol?

(NASDAQ: QTTB) Q32 Bio trades on the NASDAQ under the ticker symbol QTTB. Q32 Bio stock quotes can also be displayed as NASDAQ: QTTB.

If you're new to stock investing, here's how to buy Q32 Bio stock.

What is the 52 week high and low for Q32 Bio (NASDAQ: QTTB)?

(NASDAQ: QTTB) Q32 Bio's 52-week high was $30.92, and its 52-week low was $8.24. It is currently -6.57% from its 52-week high and 250.44% from its 52-week low.

How much is Q32 Bio stock worth today?

(NASDAQ: QTTB) Q32 Bio currently has 3,229,641 outstanding shares. With Q32 Bio stock trading at $28.89 per share, the total value of Q32 Bio stock (market capitalization) is $93.30M.

Q32 Bio stock was originally listed at a price of $335.88 in Mar 28, 2018. If you had invested in Q32 Bio stock at $335.88, your return over the last 6 years would have been -91.4%, for an annualized return of -33.56% (not including any dividends or dividend reinvestments).

How much is Q32 Bio's stock price per share?

(NASDAQ: QTTB) Q32 Bio stock price per share is $28.89 today (as of Apr 12, 2024).

What is Q32 Bio's Market Cap?

(NASDAQ: QTTB) Q32 Bio's market cap is $93.30M, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Q32 Bio's market cap is calculated by multiplying QTTB's current stock price of $28.89 by QTTB's total outstanding shares of 3,229,641.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.